Cancer is a disease that continues to be wide reaching, a leading cause of death and impacts every demographic. In 2026, according to the American Cancer Society, the U.S. expects more than 2.1 million new cancer cases, more than 600,000 deaths and impacts to more than 18 million survivors. As new research is implemented, mortality rates continue to drop and treatment with more targeted therapies reduce the impact on survivors.
In this moderated discussion between leading researchers, Dr. Michael Deininger, the Deputy Director for Team & Transdisciplinary Research at the Rogel Cancer Center and Professor and Division Chief of Hematology and Oncology at the University of Michigan and Dr. Albert Koong, Division Head and Chair of the Department of Radiation Oncology at MD Anderson, will share the current state of cancer research as well as what promising therapies are on the horizon. They will share concrete examples that make these new scientific advances understandable. Topics will include targeted therapies, RAS inhibitors, precision oncology, immunotherapy, overcoming drug resistance and more. Bring your curiosity and questions and come learn about the future of cancer prevention and treatment.
